TrialThe Lancet. Infectious diseases2017

AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.

Ousmane A Koita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.